In addition, another study of patients with IBD treated with anti-cytokine (anti-TNF or anti-IL-12/23) or anti-integrin drugs used a multi-omics analysis of stools to identify associations with drug responses after 14 weeks [39]. This evidence concerns the gene TNF and inflammatory bowel disease.